A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...

The Broad Institute of MIT and Harvard is poised to receive a massive injection of cash to fund breakthroughs in the understanding and treatment of bipolar disorder and schizophrenia research. The ...

A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen ...

Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...

Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever ...

Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...

CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.

The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

Elevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ...

Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala ...

Colorado Democratic Rep. Diana DeGette, who lost her primary, was knowledgeable about biopharma, if not always a friend to ...